Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology … Authors/Task Force Members, A Vahanian, O Alfieri, F Andreotti, ... European heart journal 33 (19), 2451-2496, 2012 | 5715 | 2012 |
Circulating endothelial progenitor cells and cardiovascular outcomes N Werner, S Kosiol, T Schiegl, P Ahlers, K Walenta, A Link, M Böhm, ... New England Journal of Medicine 353 (10), 999-1007, 2005 | 2739 | 2005 |
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis U Laufs, N Werner, A Link, M Endres, S Wassmann, K Jürgens, E Miche, ... Circulation 109 (2), 220-226, 2004 | 1204 | 2004 |
Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury N Werner, S Junk, U Laufs, A Link, K Walenta, M Böhm, G Nickenig Circulation research 93 (2), e17-e24, 2003 | 1027 | 2003 |
Increased NADH-oxidase–mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system A Warnholtz, G Nickenig, E Schulz, R Macharzina, JH Bräsen, ... Circulation 99 (15), 2027-2033, 1999 | 934 | 1999 |
Cellular antioxidant effects of atorvastatin in vitro and in vivo S Wassmann, U Laufs, K Müller, C Konkol, K Ahlbory, AT Bäumer, ... Arteriosclerosis, thrombosis, and vascular biology 22 (2), 300-305, 2002 | 931 | 2002 |
Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature G Athappan, E Patvardhan, EM Tuzcu, LG Svensson, PA Lemos, ... Journal of the American College of Cardiology 61 (15), 1585-1595, 2013 | 884 | 2013 |
The joint task force on the management of valvular heart disease of the European Society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) A Vahanian, O Alfieri, F Andreotti, MJ Antunes, G Barón-Esquivias, ... The joint task force on the management of valvular heart disease of the …, 2012 | 883 | 2012 |
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species S Wassmann, U Laufs, AT Bäumer, K Müller, K Ahlbory, W Linz, G Itter, ... Hypertension 37 (6), 1450-1457, 2001 | 721 | 2001 |
The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis: Part I: Oxidative Stress and Atherogenesis G Nickenig, DG Harrison Circulation 105 (3), 393-396, 2002 | 694* | 2002 |
Estrogen increases bone marrow–derived endothelial progenitor cell production and diminishes neointima formation K Strehlow, N Werner, J Berweiler, A Link, U Dirnagl, J Priller, K Laufs, ... Circulation 107 (24), 3059-3065, 2003 | 670 | 2003 |
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis B Scheller, U Speck, C Abramjuk, U Bernhardt, M Böhm, G Nickenig Circulation 110 (7), 810-814, 2004 | 624 | 2004 |
Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment C Maack, T Kartes, H Kilter, HJ Schäfers, G Nickenig, M Böhm, U Laufs Circulation 108 (13), 1567-1574, 2003 | 620 | 2003 |
Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor S Wassmann, M Stumpf, K Strehlow, A Schmid, B Schieffer, M Böhm, ... Circulation research 94 (4), 534-541, 2004 | 617 | 2004 |
Bone marrow–derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition N Werner, J Priller, U Laufs, M Endres, M Böhm, U Dirnagl, G Nickenig Arteriosclerosis, thrombosis, and vascular biology 22 (10), 1567-1572, 2002 | 606 | 2002 |
Modulation of antioxidant enzyme expression and function by estrogen K Strehlow, S Rotter, S Wassmann, O Adam, C Grohé, K Laufs, M Böhm, ... Circulation research 93 (2), 170-177, 2003 | 597 | 2003 |
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice U Laufs, K Gertz, P Huang, G Nickenig, M Böhm, U Dirnagl, M Endres Stroke 31 (10), 2442-2449, 2000 | 594 | 2000 |
Modulation of oxidant and antioxidant enzyme expression and function in vascular cells S Wassmann, K Wassmann, G Nickenig Hypertension 44 (4), 381-386, 2004 | 555 | 2004 |
Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men G Nickenig, AT Bäumer, Y Temur, D Kebben, F Jockenhövel, ... Circulation 100 (21), 2131-2134, 1999 | 542 | 1999 |
Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo G Nickenig, AT Bäumer, C Grohè, S Kahlert, K Strehlow, S Rosenkranz, ... Circulation 97 (22), 2197-2201, 1998 | 542 | 1998 |